Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Mar 2026: US imaging group RadNet agreed to acquire Gleamer for up to €230m in cash, to be integrated into its AI subsidiary DeepHealth.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches or cyber incidents involving Gleamer found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No recalls, safety notices or other regulatory actions involving Gleamer found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
Jan 2026: Northern Ireland deployed Gleamer's BoneView fracture-detection AI for emergency departments through PACS supplier Sectra.